FREEMAN KEVIN D bought GALT
December 23, 2025 · Form 4 insider transaction
FREEMAN KEVIN D bought 5,500 shares of Galectin Therapeutics Inc. at $3.55 per share, a transaction worth $19.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,500
Price
$3.55
Total value
$19.5K
InsiderFREEMAN KEVIN D
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 23, 2025
Filing dateDecember 23, 2025
Shares owned after55,269
OwnershipDirect
10b5-1 planNo
AmendedNo